Microsoft is steering away from creating uncontrollable general-purpose AI and turning toward Humanist Superintelligence, a new approach designed to prioritize human oversight and social benefit.
Eko Health's AI technology has shown groundbreaking potential in a new study conducted by Imperial College London, demonstrating its ability to predict major adverse cardiac events (MACE) and mortality with unmatched accuracy. By using Eko's Low Ejection Fraction AI, researchers identified patients with a significantly higher risk of heart attacks, heart failure, and hospitalization.
